Next Article in Journal
Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?
Previous Article in Journal
The Flavin Reductase MsuE Is a Novel Nitroreductase that Can Efficiently Activate Two Promising Next-Generation Prodrugs for Gene-Directed Enzyme Prodrug Therapy
Previous Article in Special Issue
Role of Hydroxamate-Based Histone Deacetylase Inhibitors (Hb-HDACIs) in the Treatment of Solid Malignancies
Cancers 2013, 5(3), 998-1019; doi:10.3390/cancers5030998

Notes on Article Versions

NoteDate
Article Published9 August 2013 11:19 CEST
article pdf uploaded.9 August 2013 11:19 CEST
article word file uploaded.9 August 2013 11:19 CEST
article files uploaded.9 August 2013 11:19 CEST
article files uploaded.9 August 2013 11:19 CEST
article files uploaded.9 August 2013 11:19 CEST
article files uploaded.9 August 2013 11:19 CEST
article xml file uploaded14 October 2013 12:15 CEST
article html file updated14 October 2013 12:15 CEST
article html file updated17 June 2015 12:12 CEST
Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert